Detalhe da pesquisa
1.
Blockade of DDR1/PYK2/ERK signaling suggesting SH2 superbinder as a novel autophagy inhibitor for pancreatic cancer.
Cell Death Dis
; 14(12): 811, 2023 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071340
2.
Blockade of phosphotyrosine pathways suggesting SH2 superbinder as a novel therapy for pulmonary fibrosis.
Theranostics
; 12(10): 4513-4535, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35832075
3.
Aptamer-SH2 superbinder-based targeted therapy for pancreatic ductal adenocarcinoma.
Clin Transl Med
; 11(3): e337, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33783993
4.
N-acetylcysteine decreases malignant characteristics of glioblastoma cells by inhibiting Notch2 signaling.
J Exp Clin Cancer Res
; 38(1): 2, 2019 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30606241
5.
Development of novel affinity reagents for detecting protein tyrosine phosphorylation based on superbinder SH2 domain in tumor cells.
Anal Chim Acta
; 1032: 138-146, 2018 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30143211
6.
(Arg)9-SH2 superbinder: a novel promising anticancer therapy to melanoma by blocking phosphotyrosine signaling.
J Exp Clin Cancer Res
; 37(1): 138, 2018 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29976230
7.
A phosphorylation switch controls the spatiotemporal activation of Rho GTPases in directional cell migration.
Nat Commun
; 6: 7721, 2015 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26166433
8.
Erratum: a phosphorylation switch controls the spatiotemporal activation of Rho GTPases in directional cell migration.
Nat Commun
; 6: 8320, 2015 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26346464